Trial Information

Summary: PHII-80 PHL-051 NCI #7502: A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas

You have been asked to participate in this research study because you have sarcoma (a cancer of smooth muscle) from the uterus or ovary (also called a gynecologic sarcoma) that has spread and cannot be cured by surgery. The purpose of this study is to learn more about an investigational agent called VEGF-Trap with respect to its ability to cause tumor shrinkage or to stop the growth of gynecological sarcomas, as well as to learn more about side effects of this drug.    Your treatment on this study is expected to last for as long as your cancer is not growing and you are not having any unmanageable side effects.  After your treatment on this study is over, your medical condition will be followed indefinitely.

Patient Inclusion/Exclusion Criteria:

- See http://clinicaltrials.coh.org for additional information.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: July 7, 2008 at 3:25:58 PM